We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
-6.12%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.96B
AUM Growth
-$641M
(-11%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
23.33%
Holding
765
New
46
Increased
242
Reduced
270
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Manhattan Associates
MANH
|
+$33.6M |
| 2 |
Amazon
AMZN
|
+$32.3M |
| 3 |
CEB
CEB Inc.
CEB
|
+$27.7M |
| 4 |
Gilead Sciences
GILD
|
+$27.3M |
| 5 |
Merck
MRK
|
+$25.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$49.9M |
| 2 |
TWX
Time Warner Inc
TWX
|
+$30.5M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
+$29.3M |
| 4 |
MIC
Macquarie Infrastructure Holdings, LLC
MIC
|
+$25M |
| 5 |
Sunoco
SUN
|
+$21.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.16% |
| 2 | Financials | 16.84% |
| 3 | Consumer Discretionary | 14.26% |
| 4 | Technology | 13.32% |
| 5 | Industrials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Canadian Pacific Kansas City
CP
$82.5B
| $781K | 0.02% |
27,200
-4,600
| -14% | -$139K |
|
302
Mondelez International
MDLZ
$79.7B
| $781K | 0.02% |
18,647
+1,419
| +8% | +$61.1K |
|
|
BXLT
303
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| $772K | 0.02% |
+24,498
| New | +$845K |
|
304
Emerson Electric
EMR
$88B
| $727K | 0.01% |
16,467
-3,891
| -19% | -$191K |
|
305
Lowe's Companies
LOW
$116B
| $726K | 0.01% |
10,531
+145
| +1% | +$9.97K |
|
306
Teva Pharmaceuticals
TEVA
$43.8B
| $713K | 0.01% |
12,620
-710
| -5% | -$46K |
|
|
ENH.PRA
307
DELISTED
ENDURANCE SPECIALTY HOLDINGS LTD PFD SER A
ENH.PRA
| $704K | 0.01% |
27,700
+4,200
| +18% | +$108K |
|
308
Papa John's
PZZA
$765M
| $681K | 0.01% |
9,950
-10,605
| -52% | -$764K |
|
309
Thermo Fisher Scientific
TMO
$233B
| $671K | 0.01% |
5,486
+3,759
| +218% | +$490K |
|
310
Franco-Nevada
FNV
$52.3B
| $669K | 0.01% |
15,205
-1,650
| -10% | -$71.1K |
|
|
CLA.CL
311
DELISTED
Capitala Finance Corp.
CLA.CL
| $664K | 0.01% |
26,300
+1,000
| +4% | +$25.6K |
|
312
Celanese
CE
$4.92B
| $663K | 0.01% |
11,208
-465
| -4% | -$29.5K |
|
313
Simon Property Group
SPG
$69.5B
| $657K | 0.01% |
3,574
-40
| -1% | -$7.33K |
|
314
Vanguard S&P 500 ETF
VOO
$1.03T
| $649K | 0.01% |
3,696
+1,041
| +39% | +$194K |
|
315
Ingredion
INGR
$6.53B
| $647K | 0.01% |
7,415
-335
| -4% | -$28.7K |
|
316
Northern Trust
NTRS
$34.1B
| $638K | 0.01% |
9,361
+1
| +0% | +$73 |
|
317
Snap-on
SNA
$20.5B
| $634K | 0.01% |
4,203
| – | – |
|
|
XENT
318
DELISTED
Intersect ENT, Inc
XENT
| $630K | 0.01% |
26,935
+10,711
| +66% | +$296K |
|
319
iShares Preferred and Income Securities ETF
PFF
$13.1B
| $616K | 0.01% |
15,962
+95
| +0.6% | +$3.71K |
|
320
Diageo
DEO
$51.2B
| $605K | 0.01% |
5,610
-306
| -5% | -$34K |
|
|
CTRA
321
DELISTED
Coterra Energy
CTRA
| $603K | 0.01% |
27,591
-32
| -0.1% | -$819 |
|
|
LLTC
322
DELISTED
Linear Technology Corp
LLTC
| $600K | 0.01% |
+14,875
| New | +$610K |
|
323
Core Laboratories
CLB
$564M
| $598K | 0.01% |
5,990
+2,950
| +97% | +$321K |
|
324
Duke Energy
DUK
$94.2B
| $591K | 0.01% |
8,210
-151
| -2% | -$10.9K |
|
325
ONE Gas
OGS
$5B
| $589K | 0.01% |
12,984
-910
| -7% | -$39.9K |
|
Similar funds
CAM
VKH
DL
RBC
TCM
HCM
AL
AT
Geneva Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, Geneva Advisors held 765 positions worth $4.96B, down 11% from $5.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geneva Advisors withdrew a net $193M in Q3 2015, closing 98 positions and reducing 270 holdings. Its most notable exit was Potash Corp Of Saskatchewan, an estimated $21.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Geneva Advisors opened a new position in Alphabet (Google) Class A worth $15.8M.
- Geneva Advisors's largest Q3 2015 buy was Alphabet (Google) Class A: 496,420 shares worth $15.8M.
- Geneva Advisors added most to Manhattan Associates in Q3 2015, an estimated $33.6M increase.
- Geneva Advisors's biggest Q3 2015 reduction was Biogen, cutting an estimated $49.9M.
- Geneva Advisors fully exited Potash Corp Of Saskatchewan in Q3 2015, selling an estimated $21.6M.
- Geneva Advisors's ten largest holdings make up 23% of its $4.96B portfolio in Q3 2015.
- Geneva Advisors opened 46 new positions and closed 98 in Q3 2015.
- Geneva Advisors's portfolio value fell 11% quarter-over-quarter to $4.96B.
Based on Geneva Advisors's 13F filing for Q3 2015, filed 3 Nov 2015.